Stocks/IBIO

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

IBIO

↓ PDF (Pro)
iBio Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$1.73
+7.45%today
MKT CAP
$63M
-21.4% · 1Y
Earnings History
-53.1%
+12.3%
-50.0%
-38.5%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$1.73
Low
$4.20
Analyst Mean
$5.37
High
$7.00
6 analystsNone
Full Financials
Trailing P/E-
Forward P/E-5.7x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-100.0%
5y Revenue CAGR-44.8%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership2.4%
Institutional Ownership49.4%
Short % of Float10.62%
Days to Cover3.9d
1 Week-4.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
BANJAK MARCOfficerBuy13,934$1.64$0.02M2026-03-26
BRENNER MARTINChief Executive OfficerBuy12,336$2.02$0.02M2026-03-19
DURAN FELIPEChief Financial OfficerBuy24,835$2.02$0.05M2026-03-19
ARKOWITZ DAVID A.DirectorBuy18,382$2.72$0.05M2025-01-10
CLARK WILLIAM DDirectorBuy1,838$2.72$0.00M2025-01-10
Top Holders
HolderType% HeldValueΔ SharesAs of
EcoR1 Capital, LLCinstitution6.16%$0.00B+100.00%2025-12-31
Affinity Asset Advisors, Llcinstitution5.69%$0.00B+100.00%2025-12-31
Logos Global Management LPinstitution5.53%$0.00B+100.00%2025-12-31
Frazier Life Sciences Management, L.P. institution5.40%$0.00B+100.00%2025-12-31
Balyasny Asset Management LPinstitution3.03%$0.00B+10440.18%2025-12-31
Ikarian Capital, LLCinstitution2.65%$0.00B+55.03%2025-12-31
Vanguard Group Incinstitution2.44%$0.00B+222.23%2025-12-31
Sio Capital Management, LLCinstitution2.05%$0.00B+100.00%2025-12-31
Ameriprise Financial, Inc.institution1.62%$0.00B+21.16%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund1.34%$0.00B+100.00%2025-12-31
Two Sigma Investments, LPinstitution1.26%$0.00B+100.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.65%$0.00B+37.06%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.34%$0.00B+4.23%2026-02-28
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.12%$0.00B+0.00%2026-02-28
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.09%$0.00B+0.00%2026-02-28
VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fundfund0.06%$0.00B+100.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.03%$0.00B+100.00%2026-02-28
Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-Stfund0.00%$0.00B+100.00%2025-12-31
Guggenheim Active Allocation Fundfund0.00%$0.00B+0.00%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for IBIO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.